C WorldWide Group’s Kite Pharma, Inc. KITE Stock Holding History

C WorldWide Group’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-58,443	Closed	-$6.06M	–	132
2017 Q2	$6.06M	Sell	58,443 -2,657	-4%	-$217K	0.09%	56
2017 Q1	$4.8M	Sell	61,100 -2,804	-4%	-$173K	0.08%	55
2016 Q4	$2.87M	Sell	63,904 -9,096	-12%	-$446K	0.06%	66
2016 Q3	$4.08M	Buy	73,000 +26,000	+55%	+$1.45M	0.07%	60
2016 Q2	$2.35M	Hold	47,000	–	–	0.05%	68
2016 Q1	$2.16M	Hold	47,000	–	–	0.04%	68
2015 Q4	$2.9M	Hold	47,000	–	–	0.05%	71
2015 Q3	$2.62M	Buy	47,000 +22,000	+88%	+$1.38M	0.04%	77
2015 Q2	$1.52M	Sell	25,000 -10,000	-29%	-$571K	0.02%	97
2015 Q1	$2.1M	Buy	+35,000	New	+$2.35M	0.03%	82

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

C WorldWide Group's KITE Position: Q3 2017 in Review

C WorldWide Group sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 58,443 shares — an estimated $6.06M sold.

C WorldWide Group first reported a position in KITE in Q1 2015 and held it in 10 quarters. The position peaked at $6.06M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

C WorldWide Group reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
C WorldWide Group sold 58,443 Kite Pharma, Inc. shares in Q3 2017, an estimated $6.06M.
C WorldWide Group first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 10 quarters.
C WorldWide Group's Kite Pharma, Inc. position peaked at $6.06M in Q2 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on C WorldWide Group's 13F filing for Q3 2017, filed 6 Nov 2017.